Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biofrontera (BFRI) Non Operating Investment Income (2022 - 2025)

Biofrontera has reported Non Operating Investment Income over the past 4 years, most recently at -$1000.0 for Q4 2025.

  • For Q4 2025, Non Operating Investment Income rose 50.0% year-over-year to -$1000.0; the TTM value through Sep 2025 reached -$1000.0, up 99.87%, while the annual FY2025 figure was $2000.0, 114.29% up from the prior year.
  • Non Operating Investment Income for Q4 2025 was -$1000.0 at Biofrontera, down from $1000.0 in the prior quarter.
  • Over five years, Non Operating Investment Income peaked at $1.7 million in Q4 2022 and troughed at -$2.9 million in Q1 2023.
  • A 4-year average of -$473916.7 and a median of -$2000.0 in 2024 define the central range for Non Operating Investment Income.
  • Biggest five-year swings in Non Operating Investment Income: plummeted 144.99% in 2023 and later soared 150.0% in 2025.
  • Year by year, Non Operating Investment Income stood at $1.7 million in 2022, then crashed by 144.99% to -$786000.0 in 2023, then surged by 99.75% to -$2000.0 in 2024, then skyrocketed by 50.0% to -$1000.0 in 2025.
  • Business Quant data shows Non Operating Investment Income for BFRI at -$1000.0 in Q4 2025, $1000.0 in Q3 2025, and $2000.0 in Q2 2025.